Numer badania | Tytuł badania | Nowotwór | Kategoria chorych | Faza badania | Sponsor badania | Data rozpoczęcia | Data zakończenia | Ośrodki badawcze | Sponsor badania | Linki |
---|---|---|---|---|---|---|---|---|---|---|
NCT01204749 | TRINOVA-1: A Study of AMG 386 or Placebo, in Combination... | rak jajnika | po operacji | III | Amgen | 2010-09-30 | 2017-03-31 |
Bydgoszcz; Gdańsk; Lublin; Poznań; Warszawa
|
Amgen | |
NCT01360554 | ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib... | n. rak płuca | po 1. lub 2. linii IIIB/IV | III | Pfizer | 2011-05-31 | 2013-01-31 |
Otwock; Warszawa
|
Pfizer | |
NCT01232556 | A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive... | NHL | oporny/nawrotowy | III | Pfizer | 2011-03-31 | 2015-11-30 |
Warszawa
|
Pfizer | |
NCT01001377 | ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to... | rak jelita grubego | przerzutowy/chemiooporny | III | Amgen | 2010-01-31 | 2013-07-31 |
Elbląg; Gdańsk; Jelenia Góra; Poznań; Szczecin; Warszawa
|
Amgen | |
NCT01098266 | NGR015: Study in Second Line for Patient With Advanced Malignant... | międzybłoniak opłucnej | 1sza linia leczenia | III | MolMed | 2010-02-28 | 2013-01-31 |
UCK Gdańsk - Jacek Jassem; CO-I Warszawa - Paweł Badurak |
MolMed | |
NCT00646854 | Alemtuzumab and CHOP in T-cell Lymphoma | chłoniak T-kom | 1sza linia leczenia | III | Aarhus Universitetshospital | 2008-05-31 | 2016-11-30 |
CO-I Warszawa; prof.J.Walewski, walewski@coi.waw.pl
|
Aarhus Universitetshospital | |
NCT00883792 | The Northern-European Initiative on Colorectal Cancer | rak jelita | skrining | III | Norwegian Ministry of Health | 2009-04-30 | 2036-06-30 |
CO-I Warszawa - Jaroslaw Regula, MD PhD Ph: 48 606... |
Norwegian Ministry of Health | |
NCT01387282 | Safety and Efficacy of Anamorelin HCl in Patients With Non-Small... | n. rak płuca | zaawansowany nowotwór | III | Helsinn Healthcare | 2011-06-30 | 2013-06-30 |
Bydgoszcz; Grudziądz; Katowice; Kraków; Łódź; Lublin; Szczecin; Warszawa
|
Helsinn Healthcare | |
NCT00209222 | Efficacy of Rituximab - Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP)... | chłoniak płaszcza | 1sza linia leczenia | III | University of Cologne | 2004-06-30 | 2010-05-31 |
Jan Walewski; Ph: +48-22-546-2223;
|
University of Cologne | |
NCT00375674 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus... | rak nerki | po resekcji/uzupełniająco | III | Pfizer | 2007-06-30 | 2017-05-31 |
Łódź; Poznań; Warszawa; Kraków
|
Pfizer |